{Reference Type}: Case Reports
{Title}: A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency (MADD) with a novel mutation in ETFDH gene.
{Author}: Zhuo Z;Jin P;Li F;Li H;Chen X;Wang H;
{Journal}: J Neurol Sci
{Volume}: 353
{Issue}: 1
{Year}: 2015
{Factor}: 4.553
{DOI}: 10.1016/j.jns.2015.04.011
{Abstract}: We report a novel mutation in the electron transfer flavoprotein dehydrogenase (EFTDH) gene in an adolescent Chinese patient with late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD) characterized by muscle weakness as early symptom. At the age of 9 years, the patient experienced progressive muscle weakness. Blood creatine kinase level and aminotransferase were higher than normal. The muscle biopsy revealed lipid storage myopathy. Serum acylcarnitine and urine organic acid analyses were consistent with MADD. Genetic mutation analysis revealed a compound heterozygous mutation in EFTDH gene. The patients showed good response to riboflavin and l-carnitine treatment.